Saturday, July 11, 2026

pharma · Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome)

Esteve Pharmaceuticals

Esteve Pharmaceuticals patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Barcelona, ES HQ
46 Employees
EMA registrant Type
Company details
Status
Public
HQ
Barcelona, ES
Employees
46
Programs
1
Drugs
3
Patents
0
Intelligence · Patents

Esteve Pharmaceuticals patents

0 pharmaceutical patents indexed for Esteve Pharmaceuticals. 0 expire within 24 months.

Esteve Pharmaceuticals has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Esteve Pharmaceuticals have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Esteve Pharmaceuticals patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.